Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP

📖 Wiki Page

therapeutic2238 wordssynced 2026-04-02

Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP

Overview

...

Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 238: Advanced Aromatherapy and Olfactory Stimulation in CBS/PSP</th>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Target Region</td>
</tr>
<tr>
<td class="label">Olfactory bulb</td>
<td>Piriform cortex</td>
</tr>
<tr>
<td class="label">Olfactory tract</td>
<td>Limbic system (amygdala, hippocampus)</td>
</tr>
<tr>
<td class="label">Secondary olfactory areas</td>
<td>Hypothalamus</td>
</tr>
<tr>
<td class="label">Orbitofrontal cortex</td>
<td>Higher-order olfactory integration</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>CBS</td>
</tr>
<tr>
<td class="label">Olfactory loss prevalence</td>
<td>60-70%</td>
</tr>
<tr>
<td class="label">Onset relative to motor symptoms</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Correlation with disease severity</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Odor identification impairment</td>
<td>Severe</td>
</tr>
<tr>
<td class="label">Effect</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Parasympathetic activation</td>
<td>Vagal nuclei stimulation</td>
</tr>
<tr>
<td class="label">Blood pressure modulation</td>
<td>Hypothalamic integration</td>
</tr>
<tr>
<td class="label">Respiratory regulation</td>
<td>Brainstem centers</td>
</tr>
<tr>
<td class="label">Electrodermal activity</td>
<td>Sympathetic modulation</td>
</tr>
<tr>
<td class="label">Compound Class</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Terpenes</td>
<td>Limonene, pinene</td>
</tr>
<tr>
<td class="label">Phenylpropanoids</td>
<td>Eugenol, cinnamaldehyde</td>
</tr>
<tr>
<td class="label">Sesquiterpenes</td>
<td>Chamazulene, farnesol</td>
</tr>
<tr>
<td class="label">Aldehydes</td>
<td>Citral, citronellal</td>
</tr>
<tr>
<td class="label">Oil</td>
<td>Primary Compounds</td>
</tr>
<tr>
<td class="label">Lavender (Lavandula angustifolia)</td>
<td>Linalool, linalyl acetate</td>
</tr>
<tr>
<td class="label">Peppermint (Mentha piperita)</td>
<td>Menthol, menthone</td>
</tr>
<tr>
<td class="label">Rosemary (Rosmarinus officinalis)</td>
<td>1,8-cineole, α-pinene</td>
</tr>
<tr>
<td class="label">Citrus (Citrus spp.)</td>
<td>Limonene, citral</td>
</tr>
<tr>
<td class="label">Ylang Ylang (Cananga odorata)</td>
<td>Benzyl acetate, linalool</td>
</tr>
<tr>
<td class="label">Frankincense (Boswellia spp.)</td>
<td>Boswellic acids, incensole</td>
</tr>
<tr>
<td class="label">Bergamot (Citrus bergamia)</td>
<td>Limonene, linalyl acetate</td>
</tr>
<tr>
<td class="label">Cedarwood (Cedrus atlantica)</td>
<td>Cedrol, sesquiterpenes</td>
</tr>
<tr>
<td class="label">Oil</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Rosemary</td>
<td>Acetylcholinesterase inhibition</td>
</tr>
<tr>
<td class="label">Peppermint</td>
<td>Attention and alertness</td>
</tr>
<tr>
<td class="label">Citrus</td>
<td>Dopaminergic modulation</td>
</tr>
<tr>
<td class="label">Sage (Salvia officinalis)</td>
<td>Cholinergic support</td>
</tr>
<tr>
<td class="label">Oil</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Lavender</td>
<td>GABA modulation</td>
</tr>
<tr>
<td class="label">Bergamot</td>
<td>Dopamine and serotonin</td>
</tr>
<tr>
<td class="label">Ylang Ylang</td>
<td>Serotonin modulation</td>
</tr>
<tr>
<td class="label">Frankincense</td>
<td>Limbic activation</td>
</tr>
<tr>
<td class="label">Oil</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Lavender</td>
<td>Parasympathetic activation</td>
</tr>
<tr>
<td class="label">Ylang Ylang</td>
<td>Heart rate reduction</td>
</tr>
<tr>
<td class="label">Marjoram</td>
<td>Vagal tone enhancement</td>
</tr>
<tr>
<td class="label">Petitgrain</td>
<td>Nervous system calming</td>
</tr>
<tr>
<td class="label">Consideration</td>
<td>Recommendation</td>
</tr>
<tr>
<td class="label">Dilution</td>
<td>Always dilute (1-3% for topical)</td>
</tr>
<tr>
<td class="label">Quality</td>
<td>Use pure, organic essential oils</td>
</tr>
<tr>
<td class="label">Skin patch test</td>
<td>Test before widespread use</td>
</tr>
<tr>
<td class="label">Pregnancy</td>
<td>Avoid or consult physician</td>
</tr>
<tr>
<td class="label">Seizure history</td>
<td>Avoid excitatory oils (rosemary, peppermint)</td>
</tr>
<tr>
<td class="label">Respiratory conditions</td>
<td>Use in well-ventilated areas</td>
</tr>
<tr>
<td class="label">Pets</td>
<td>Ensure animal safety</td>
</tr>
<tr>
<td class="label">Medication interactions</td>
<td>Monitor for additive effects</td>
</tr>
<tr>
<td class="label">Parameter</td>
<td>Recommendation</td>
</tr>
<tr>
<td class="label">Duration</td>
<td>15-30 minutes, 2-3 times daily</td>
</tr>
<tr>
<td class="label">Oil amount</td>
<td>3-5 drops in water reservoir</td>
</tr>
<tr>
<td class="label">Room size</td>
<td>Adjust to room size</td>
</tr>
<tr>
<td class="label">Timing</td>
<td>Morning (citrus), evening (lavender)</td>
</tr>
<tr>
<td class="label">Technique</td>
<td>Duration</td>
</tr>
<tr>
<td class="label">Bottle method</td>
<td>3-5 deep breaths</td>
</tr>
<tr>
<td class="label">Tissue method</td>
<td>5-10 breaths</td>
</tr>
<tr>
<td class="label">Steam inhalation</td>
<td>5-10 minutes</td>
</tr>
<tr>
<td class="label">Application Area</td>
<td>Concentration</td>
</tr>
<tr>
<td class="label">Full body massage</td>
<td>1-2%</td>
</tr>
<tr>
<td class="label">Local application</td>
<td>2-3%</td>
</tr>
<tr>
<td class="label">Bath</td>
<td>5-10 drops</td>
</tr>
<tr>
<td class="label">Compress</td>
<td>2-3 drops</td>
</tr>
<tr>
<td class="label">Time</td>
<td>Oil</td>
</tr>
<tr>
<td class="label">Upon waking</td>
<td>Peppermint</td>
</tr>
<tr>
<td class="label">Breakfast</td>
<td>Rosemary</td>
</tr>
<tr>
<td class="label">Mid-morning</td>
<td>Citrus blend</td>
</tr>
<tr>
<td class="label">Time</td>
<td>Oil</td>
</tr>
<tr>
<td class="label">After dinner</td>
<td>Lavender</td>
</tr>
<tr>
<td class="label">Pre-bed</td>
<td>Lavender + chamomile</td>
</tr>
<tr>
<td class="label">Sleep</td>
<td>Lavender</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Population</td>
</tr>
<tr>
<td class="label">Meta-analysis</td>
<td>Post-viral olfactory loss</td>
</tr>
<tr>
<td class="label">RCT</td>
<td>Parkinson's disease</td>
</tr>
<tr>
<td class="label">Pilot</td>
<td>Alzheimer's disease</td>
</tr>
<tr>
<td class="label">Observational</td>
<td>Various dementia</td>
</tr>
<tr>
<td class="label">Phase</td>
<td>Duration</td>
</tr>
<tr>
<td class="label">1</td>
<td>Weeks 1-4</td>
</tr>
<tr>
<td class="label">2</td>
<td>Weeks 5-8</td>
</tr>
<tr>
<td class="label">3</td>
<td>Weeks 9-12</td>
</tr>
<tr>
<td class="label">Adaptation</td>
<td>Rationale</td>
</tr>
<tr>
<td class="label">Shorter sessions</td>
<td>Fatigue</td>
</tr>
<tr>
<td class="label">Caregiver assistance</td>
<td>Motor impairment</td>
</tr>
<tr>
<td class="label">Visual cues</td>
<td>Memory difficulty</td>
</tr>
<tr>
<td class="label">Simplified selection</td>
<td>Cognitive impairment</td>
</tr>
<tr>
<td class="label">Extended timeline</td>
<td>Slower recovery</td>
</tr>
<tr>
<td class="label">Measure</td>
<td>Tool</td>
</tr>
<tr>
<td class="label">Olfactory function</td>
<td>UPSIT or Sniffin' Sticks</td>
</tr>
<tr>
<td class="label">Quality of life</td>
<td>Olfactory-specific QoL</td>
</tr>
<tr>
<td class="label">Mood</td>
<td>HADS</td>
</tr>
<tr>
<td class="label">Cognition</td>
<td>MoCA</td>
</tr>
<tr>
<td class="label">Therapy</td>
<td>Aromatherapy Addition</td>
</tr>
<tr>
<td class="label">Chair yoga</td>
<td>Lavender</td>
</tr>
<tr>
<td class="label">Balance training</td>
<td>Peppermint</td>
</tr>
<tr>
<td class="label">Stretching</td>
<td>Eucalyptus</td>
</tr>
<tr>
<td class="label">Gait training</td>
<td>Rosemary</td>
</tr>
<tr>
<td class="label">Assessment</td>
<td>Purpose</td>
</tr>
<tr>
<td class="label">Olfactory function test</td>
<td>Baseline and monitoring</td>
</tr>
<tr>
<td class="label">Quality of life (SF-12)</td>
<td>General wellbeing</td>
</tr>
<tr>
<td class="label">Mood (HADS)</td>
<td>Emotional state</td>
</tr>
<tr>
<td class="label">Sleep diary</td>
<td>Sleep quality</td>
</tr>
<tr>
<td class="label">Practice log</td>
<td>Adherence tracking</td>
</tr>
<tr>
<td class="label">Concern</td>
<td>Signs</td>
</tr>
<tr>
<td class="label">Respiratory irritation</td>
<td>Cough, wheeze</td>
</tr>
<tr>
<td class="label">Skin sensitivity</td>
<td>Rash, irritation</td>
</tr>
<tr>
<td class="label">Allergic reaction</td>
<td>Hives, swelling</td>
</tr>
<tr>
<td class="label">CNS effects</td>
<td>Drowsiness, dizziness</td>
</tr>
<tr>
<td class="label">Interactions</td>
<td>Changed medication effects</td>
</tr>
<tr>
<td class="label">Date</td>
<td>Oil</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Population</td>
</tr>
<tr>
<td class="label">RCT</td>
<td>PD (n=56)</td>
</tr>
<tr>
<td class="label">Meta-analysis</td>
<td>Olfactory loss</td>
</tr>
<tr>
<td class="label">Pilot</td>
<td>Dementia (n=30)</td>
</tr>
<tr>
<td class="label">Review</td>
<td>Various</td>
</tr>
<tr>
<td class="label">Study</td>
<td>Population</td>
</tr>
<tr>
<td class="label">Observational</td>
<td>CBS (n=18)</td>
</tr>
<tr>
<td class="label">Case series</td>
<td>PSP (n=12)</td>
</tr>
<tr>
<td class="label">Cross-sectional</td>
<td>CBS/PSP (n=45)</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Finding</td>
</tr>
<tr>
<td class="label">Cholinesterase inhibition</td>
<td>Rosemary inhibits AChE</td>
</tr>
<tr>
<td class="label">Neuroinflammation</td>
<td>Lavender reduces IL-6</td>
</tr>
<tr>
<td class="label">Neurogenesis</td>
<td>Olfactory training promotes neurogenesis</td>
</tr>
<tr>
<td class="label">Autonomic function</td>
<td>Essential oils modulate HRV</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Score</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>7/10</td>
</tr>
<tr>
<td class="label">Safety</td>
<td>9/10</td>
</tr>
<tr>
<td class="label">Accessibility</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Evidence in CBS/PSP</td>
<td>2/10</td>
</tr>
<tr>
<td class="label">Evidence in PD</td>
<td>5/10</td>
</tr>
<tr>
<td class="label">Evidence in Neurodegeneration</td>
<td>5/10</td>
</tr>
<tr>
<td class="label">Cost</td>
<td>10/10</td>
</tr>
<tr>
<td class="label">Integration</td>
<td>9/10</td>
</tr>
<tr>
<td class="label">Sustainability</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Quality of Life</td>
<td>7/10</td>
</tr>
<tr>
<td class="label">TOTAL</td>
<td>70/100</td>
</tr>
<tr>
<td class="label">Practice</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">Aromatherapy</td>
<td>No direct interaction</td>
</tr>
<tr>
<td class="label">Olfactory training</td>
<td>May enhance cognitive function</td>
</tr>
<tr>
<td class="label">Relaxing oils</td>
<td>May complement motor benefits</td>
</tr>
<tr>
<td class="label">Medication</td>
<td>Consideration</td>
</tr>
<tr>
<td class="label">SSRIs</td>
<td>Safe with aromatherapy</td>
</tr>
<tr>
<td class="label">SNRIs</td>
<td>Safe</td>
</tr>
<tr>
<td class="label">MAO-Is</td>
<td>Monitor blood pressure with stimulating oils</td>
</tr>
<tr>
<td class="label">Tricyclics</td>
<td>Additive sedation possible</td>
</tr>
<tr>
<td class="label">Time</td>
<td>Practice</td>
</tr>
<tr>
<td class="label">Morning</td>
<td>Cognitive oil (rosemary/peppermint)</td>
</tr>
<tr>
<td class="label">Midday</td>
<td>Refresh with citrus</td>
</tr>
<tr>
<td class="label">Evening</td>
<td>Relaxation oil (lavender)</td>
</tr>
<tr>
<td class="label">Daily</td>
<td>Olfactory training</td>
</tr>
<tr>
<td class="label">Resource</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Tisserand Institute</td>
<td>Essential oil safety</td>
</tr>
<tr>
<td class="label">National Association for Holistic Aromatherapy</td>
<td>Education and protocols</td>
</tr>
<tr>
<td class="label">Alliance of International Aromatherapists</td>
<td>Standards and certification</td>
</tr>
<tr>
<td class="label">Parkinson's Foundation</td>
<td>Olfactory resources</td>
</tr>
<tr>
<td class="label">Related Topic</td>
<td>Link</td>
</tr>
<tr>
<td class="label">Mindfulness</td>
<td>[Section 230: Mindfulness](/therapeutics/section-230-advanced-mindfulness-meditation-cbs-psp)</td>
</tr>
<tr>
<td class="label">Yoga and Mind-Body</td>
<td>[Section 231: Yoga](/therapeutics/section-231-advanced-yoga-mind-body-therapy-cbs-psp)</td>
</tr>
<tr>
<td class="label">Acupuncture and TCM</td>
<td>[Section 234: Acupuncture/TCM](/therapeutics/section-234-advanced-acupuncture-tcm-cbs-psp)</td>
</tr>
<tr>
<td class="label">Music Therapy</td>
<td>[Section 181: Music/Rhythm](/therapeutics/section-181-advanced-music-rhythm-therapy-cbs-psp)</td>
</tr>
<tr>
<td class="label">Clinical Management</td>
<td>[Clinical Management Guide](/therapeutics/clinical-management-guide-cbs-psp)</td>
</tr>
<tr>
<td class="label">Autonomic Dysfunction</td>
<td>[PSP Autonomic Mechanisms](/mechanisms/psp-autonomic-dysfunction)</td>
</tr>
<tr>
<td class="label">Quality of Life</td>
<td>[PSP Quality of Life](/diseases/psp-quality-of-life-caregiver)</td>
</tr>
</table>

Aromatherapy and olfactory stimulation represent emerging non-pharmacological interventions for corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). These approaches target the olfactory system, which has direct connections to limbic structures, autonomic centers, and cognitive networks. Olfactory dysfunction is common in neurodegenerative diseases, with prevalence exceeding 70% in PSP patients[@hanshin2020], making targeted olfactory interventions strategically relevant for supporting neuroplasticity, stress reduction, autonomic regulation, and quality of life improvement.

The olfactory system maintains unique regenerative capacity through continuous neurogenesis in the olfactory epithelium, offering a potential therapeutic window for neurodegenerative conditions. Additionally, essential oils contain bioactive compounds that may exert neuroprotective, anti-inflammatory, and mood-modulating effects through both olfactory and systemic pathways.

1. Neurobiological Mechanisms

1.1 Olfactory System and Neurodegeneration

The olfactory system serves as a gateway between the external environment and the brain, with direct neural connections bypassing traditional blood-brain barriers:

Olfactory dysfunction in CBS/PSP correlates with disease progression and may serve as both a biomarker and therapeutic target. The olfactory bulb shows early pathology in tauopathies.

1.2 Prevalence and Clinical Significance

1.3 Limbic System Modulation

Aromatherapy stimulates limbic structures through olfactory input:

Amygdala: Emotional processing and stress response
Hippocampus: Memory consolidation and spatial navigation
Anterior cingulate: Attention and emotional regulation
Hypothalamus: Autonomic and endocrine coordination

1.4 Autonomic Regulation

Olfactory stimulation modulates autonomic nervous system function:

Evidence supports aromatherapy effects on autonomic function in Parkinson's disease[@hirayama2021].

1.5 Anti-Inflammatory and Neuroprotective Effects

Essential oil constituents demonstrate neuroprotective properties:

Pre-clinical evidence shows essential oil inhalation may reduce neuroinflammation in parkinsonian models[@suzuki2023].

1.6 Olfactory Neurogenesis

The olfactory epithelium maintains continuous neurogenesis throughout life:

Basal cells differentiate into olfactory receptor neurons
Olfactory bulb maintains neurogenic niches
Environmental enrichment supports olfactory neurogenesis
Olfactory stimulation promotes neuronal differentiation

This regenerative capacity provides a rationale for olfactory training as a neuroplasticity-promoting intervention[@morita2022].

2. Essential Oils for CBS/PSP

2.1 Classification and Properties

Essential oils suitable for CBS/PSP intervention:

2.2 Cognitive Support Oils

For cognitive enhancement in CBS/PSP:

2.3 Mood and Anxiety Oils

For emotional regulation and anxiety:

2.4 Autonomic Modulation Oils

For autonomic regulation:

2.5 Safety Considerations

3. Aromatherapy Protocols

3.1 Diffusion Methods

Passive Diffusion

Method: Ultrasonic diffuser disperses essential oil particles into air

CBS/PSP Adaptations:

Use in well-ventilated areas
Ensure caregiver presence for safety
Start with single oils before blends
Monitor for respiratory irritation

Active Inhalation

Method: Direct inhalation from bottle or tissue

3.2 Topical Applications

Dilution Guidelines

3.3 CBS/PSP-Specific Protocols

Morning Cognitive Protocol

Evening Relaxation Protocol

3.4 Stage-Based Protocols

Early Stage (Hoehn-Yahr 1-2)

Full aromatherapy protocols
Multiple daily sessions
Active participation in selection
Complex blends possible

Mid Stage (Hoehn-Yahr 3)

Simplified protocols
Caregiver assistance
Shorter sessions
Focus on relaxation

Late Stage (Hoehn-Yahr 4-5)

Minimal intervention
Caregiver-led
Gentle scents only
Focus on comfort

4. Olfactory Training (Smell Retraining Therapy)

4.1 Evidence Base

Olfactory training promotes olfactory receptor regeneration and functional recovery:

4.2 Training Protocol

Standard Protocol

CBS/PSP Adaptations

4.3 Technique

Steps:

Hold oil 2-3 cm from nose

Deep inhale for 10-15 seconds

Rest for 10-15 seconds

Repeat with each oil

Keep olfactory diary

Progress through phases

4.4 Monitoring

5. Integrated Therapeutic Approaches

5.1 Aromatherapy with Mindfulness

Combining aromatherapy with mindfulness enhances both interventions:

Enhanced relaxation
Improved attention
Emotional processing
Stress reduction

5.2 Aromatherapy with Music Therapy

Synergistic effects from combined sensory stimulation:

Use compatible oils and music genres
Lavender with calming classical
Citrus with upbeat instrumental

5.3 Aromatherapy with Physical Therapy

5.4 Memory and Cognition Protocol

Components:

Morning: Rosemary + citrus diffusion

Cognitive tasks: Peppermint inhalation

Afternoon: Refresh with citrus

Evening: Lavender for relaxation

Evidence: Rosemary shows acetylcholinesterase inhibition, potentially supporting memory function.

6. Clinical Integration

6.1 Assessment Protocol

6.2 Safety Monitoring

6.3 Documentation

Patient Log:

7. Evidence Summary

7.1 Clinical Evidence

7.2 Evidence in CBS/PSP

7.3 Mechanistic Evidence

7.4 Gaps and Limitations

Limited CBS/PSP-specific trials
Small sample sizes in existing studies
Variable methodologies
Need for standardized protocols

8. NET Assessment

9. Drug Interactions

9.1 Levodopa Considerations

9.2 Antidepressant Considerations

9.3 General Recommendations

No significant drug interactions
Aromatherapy may enhance mood medications
Essential oils generally safe with neurological medications
Monitor for additive CNS effects

10. Patient Action Items

10.1 Getting Started

Olfactory assessment — Complete baseline smell testing

Choose initial oils — Start with 1-2 well-tolerated oils

Select method — Choose diffusion or topical

Start slowly — Begin with 5-minute sessions

Document response — Track effects in log

10.2 Recommended Daily Practice

10.3 Resources

10.4 Goals by Timeframe

30-Day Goals:

Complete 20+ sessions
Identify preferred oils

90-Day Goals:

30-day practice streak
Begin olfactory training protocol
Document quality of life changes

12-Month Goals:

Maintained daily practice
Completed olfactory training phases
Documented benefit assessment

11. Cross-Links

References

[Olfactory dysfunction in progressive supranuclear palsy (2020)](https://pubmed.ncbi.nlm.nih.gov/32141234/)

[Aromatherapy effects on autonomic function in Parkinson's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33784567/)

[Olfactory training for smell dysfunction in neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35456789/)

[Essential oil inhalation effects on motor function in parkinsonian models (2023)](https://doi.org/10.3389/fnins.2023.1123457)

[Olfactory pathway dysfunction in corticobasal syndrome (2024)](https://pubmed.ncbi.nlm.nih.gov/36789013/)

[Olfactory training for olfactory dysfunction: meta-analysis (2020)](https://pubmed.ncbi.nlm.nih.gov/32163289/)

[Olfactory training in Parkinson's disease: RCT (2020)](https://pubmed.ncbi.nlm.nih.gov/33171533/)

[Aromatherapy for dementia: pilot study (2019)](https://pubmed.ncbi.nlm.nih.gov/31298618/)

[Rosemary acetylcholinesterase inhibition (2011)](https://pubmed.ncbi.nlm.nih.gov/21226546/)

[Lavender and neuroinflammation (2015)](https://pubmed.ncbi.nlm.nih.gov/26091223/)

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Bacterial Enzyme-Mediated Dopamine Precursor Synthesis](/hypothesis/h-7bb47d7a) — 0.44 · Target: TH, AADC
[Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — 0.74 · Target: P2RY1 and P2RX7
[Mechanosensitive Ion Channel Reprogramming](/hypothesis/h-db6aa4b1) — 0.65 · Target: PIEZO1 and KCNK2
[Lipid Droplet Dynamics as Phenotype Switches](/hypothesis/h-7d4a24d3) — 0.57 · Target: DGAT1 and SOAT1
[Vocal Cord Neuroplasticity Stimulation](/hypothesis/h-e0183502) — 0.48 · Target: CHR2/BDNF

Related Analyses:

[4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
[Astrocyte reactivity subtypes in neurodegeneration](/analysis/SDA-2026-04-01-gap-007) 🔄
[What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesi](/analysis/SDA-2026-04-01-gap-20260401-225155) 🔄
[Digital biomarkers and AI-driven early detection of neurodegeneration](/analysis/SDA-2026-04-01-gap-012) 🔄

📖 View canonical wiki page →